Search research articles
Contact Us
Filters
Showing results (1391-1400 of 1,431) with videos related to
Page
of 144
Sort By:
Brain Communications
|
November 3, 2025
Deep clinical, genetic, and serum biomarker profiling indicates glial and neuronal pathology in primary brain calcification
Janine Schwahn, Sophie Hebestreit, Olivia Kosche, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine
|
April 11, 2025
Exclusion of intracranial lesions in mild traumatic brain injury using glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1: a European multicenter study
Lara Milevoj Kopcinovic, Nora Nikolac Gabaj, Ivana Lapić, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2011
Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations
Rafael Rosell, Miguel Angel Molina, Carlota Costa, et al.
British Journal of Cancer
|
January 8, 2024
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Débora Contreras-Toledo, Paula Jiménez-Fonseca, Carlos López López, et al.
Trials
|
July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)
Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Plos Medicine
|
October 19, 2021
Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines
Simon Pollett, Michael A Johansson, Nicholas G Reich, et al.
Actas Urologicas Espanolas
|
March 17, 2025
Apalutamide use in metastatic hormone-sensitive prostate cancer patients diagnosed by conventional and next-generation imaging. Real world data from 772 patients
M Hassi Roman, K Mate, P de Pablos-RodrIguez, et al.
Nature Methods
|
April 15, 2026
Designer indicators for two-photon recording of subthreshold voltage dynamics
Michelle A Land, Mario Galdamez, Vincent Villette, et al.
European Urology Open Science
|
October 30, 2024
Prostate-specific Antigen at 3 Months as a Predictor of Radiologic Progression-free Survival in Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Analysis of 633 Patients in a Real-world Database
Mario Hassi Roman, Kinga Mate, Pedro De Pablos-Rodriguez, et al.
Plos Medicine
|
November 17, 2023
Correction: Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines
Simon Pollett, Michael A Johansson, Nicholas G Reich, et al.
Page
of 144
Search research articles
Search
Showing results (1391-1400 of 1,431) with videos related to
Sort By:
Page
of 144
Brain Communications
|
November 3, 2025
Deep clinical, genetic, and serum biomarker profiling indicates glial and neuronal pathology in primary brain calcification
Janine Schwahn, Sophie Hebestreit, Olivia Kosche, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine
|
April 11, 2025
Exclusion of intracranial lesions in mild traumatic brain injury using glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1: a European multicenter study
Lara Milevoj Kopcinovic, Nora Nikolac Gabaj, Ivana Lapić, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2011
Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations
Rafael Rosell, Miguel Angel Molina, Carlota Costa, et al.
British Journal of Cancer
|
January 8, 2024
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Débora Contreras-Toledo, Paula Jiménez-Fonseca, Carlos López López, et al.
Trials
|
July 21, 2020
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)
Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, et al.
Plos Medicine
|
October 19, 2021
Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines
Simon Pollett, Michael A Johansson, Nicholas G Reich, et al.
Actas Urologicas Espanolas
|
March 17, 2025
Apalutamide use in metastatic hormone-sensitive prostate cancer patients diagnosed by conventional and next-generation imaging. Real world data from 772 patients
M Hassi Roman, K Mate, P de Pablos-RodrIguez, et al.
Nature Methods
|
April 15, 2026
Designer indicators for two-photon recording of subthreshold voltage dynamics
Michelle A Land, Mario Galdamez, Vincent Villette, et al.
European Urology Open Science
|
October 30, 2024
Prostate-specific Antigen at 3 Months as a Predictor of Radiologic Progression-free Survival in Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Analysis of 633 Patients in a Real-world Database
Mario Hassi Roman, Kinga Mate, Pedro De Pablos-Rodriguez, et al.
Plos Medicine
|
November 17, 2023
Correction: Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines
Simon Pollett, Michael A Johansson, Nicholas G Reich, et al.
Page
of 144